China conditionally OKs Thermo Fisher's $13.6B purchase of Life


China's Commerce Ministry has conditionally approved Thermo Fisher Scientific (TMO) $13.6B acquisition of Life Technologies (LIFE).

Thermo Fisher will have to reduce the prices of two types of its products it sells in the country, and divest its cell culture and gene adjustment businesses. Thermo Fisher will also have to sell its 51% holding in China's Lanzhou National Hyclone Bio-engineering.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs